vs

Side-by-side financial comparison of BOSTON OMAHA Corp (BOC) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $29.7M, roughly 1.9× BOSTON OMAHA Corp). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 6.4%). BOSTON OMAHA Corp produced more free cash flow last quarter ($-10.0M vs $-167.0M).

Boston Omaha Corporation is a publicly traded diversified holding company. Its core operating segments include outdoor advertising, surety insurance, residential real estate development, and fixed wireless broadband services, primarily serving customers across the United States, with a focus on driving long-term shareholder value via strategic acquisitions and organic operational growth.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

BOC vs PHAT — Head-to-Head

Bigger by revenue
PHAT
PHAT
1.9× larger
PHAT
$57.6M
$29.7M
BOC
Growing faster (revenue YoY)
PHAT
PHAT
+87.8% gap
PHAT
94.1%
6.4%
BOC
More free cash flow
BOC
BOC
$157.0M more FCF
BOC
$-10.0M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOC
BOC
PHAT
PHAT
Revenue
$29.7M
$57.6M
Net Profit
$-6.9M
Gross Margin
64.0%
86.7%
Operating Margin
-4.2%
Net Margin
-23.1%
Revenue YoY
6.4%
94.1%
Net Profit YoY
-228.1%
71.6%
EPS (diluted)
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOC
BOC
PHAT
PHAT
Q4 25
$29.7M
$57.6M
Q3 25
$28.7M
$49.5M
Q2 25
$28.2M
$39.5M
Q1 25
$27.7M
$28.5M
Q4 24
$27.9M
$29.7M
Q3 24
$27.7M
$16.4M
Q2 24
$27.1M
$7.3M
Q1 24
$25.6M
Net Profit
BOC
BOC
PHAT
PHAT
Q4 25
$-6.9M
Q3 25
$-2.6M
$-30.0M
Q2 25
$-2.3M
$-75.8M
Q1 25
$-669.3K
$-94.3M
Q4 24
$5.3M
Q3 24
$-1.6M
$-85.6M
Q2 24
$-2.2M
$-91.4M
Q1 24
$-2.8M
Gross Margin
BOC
BOC
PHAT
PHAT
Q4 25
64.0%
86.7%
Q3 25
66.2%
87.5%
Q2 25
66.1%
87.2%
Q1 25
67.3%
86.9%
Q4 24
69.5%
87.1%
Q3 24
67.5%
85.6%
Q2 24
68.2%
81.2%
Q1 24
67.9%
Operating Margin
BOC
BOC
PHAT
PHAT
Q4 25
-4.2%
Q3 25
-3.7%
-30.8%
Q2 25
-2.9%
-151.7%
Q1 25
-2.9%
-276.5%
Q4 24
-4.6%
Q3 24
-2.7%
-433.0%
Q2 24
-16.2%
-1055.4%
Q1 24
-8.1%
Net Margin
BOC
BOC
PHAT
PHAT
Q4 25
-23.1%
Q3 25
-9.0%
-60.5%
Q2 25
-8.2%
-191.9%
Q1 25
-2.4%
-330.7%
Q4 24
19.1%
Q3 24
-5.8%
-523.3%
Q2 24
-8.3%
-1248.6%
Q1 24
-11.0%
EPS (diluted)
BOC
BOC
PHAT
PHAT
Q4 25
$-0.23
Q3 25
$-0.08
$-0.41
Q2 25
$-0.07
$-1.05
Q1 25
$-0.02
$-1.31
Q4 24
$0.17
Q3 24
$-0.05
$-1.32
Q2 24
$-0.07
$-1.56
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOC
BOC
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$56.8M
$130.0M
Total DebtLower is stronger
$25.7M
$209.1M
Stockholders' EquityBook value
$516.1M
$-438.2M
Total Assets
$713.1M
$259.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOC
BOC
PHAT
PHAT
Q4 25
$56.8M
$130.0M
Q3 25
$67.6M
$135.2M
Q2 25
$68.6M
$149.6M
Q1 25
$69.2M
$212.3M
Q4 24
$73.2M
$297.3M
Q3 24
$58.6M
$334.7M
Q2 24
$53.1M
$276.2M
Q1 24
$53.4M
Total Debt
BOC
BOC
PHAT
PHAT
Q4 25
$25.7M
$209.1M
Q3 25
$25.9M
$207.1M
Q2 25
$26.1M
$205.1M
Q1 25
$26.3M
$203.2M
Q4 24
$26.5M
$201.4M
Q3 24
$26.7M
$175.7M
Q2 24
$26.9M
$174.4M
Q1 24
$27.1M
Stockholders' Equity
BOC
BOC
PHAT
PHAT
Q4 25
$516.1M
$-438.2M
Q3 25
$528.4M
$-422.5M
Q2 25
$531.0M
$-405.8M
Q1 25
$533.3M
$-338.4M
Q4 24
$532.8M
$-253.6M
Q3 24
$527.7M
$-187.1M
Q2 24
$530.5M
$-233.8M
Q1 24
$536.2M
Total Assets
BOC
BOC
PHAT
PHAT
Q4 25
$713.1M
$259.1M
Q3 25
$721.4M
$240.3M
Q2 25
$730.6M
$250.2M
Q1 25
$730.8M
$294.2M
Q4 24
$728.3M
$378.3M
Q3 24
$711.9M
$387.0M
Q2 24
$723.1M
$319.4M
Q1 24
$757.3M
Debt / Equity
BOC
BOC
PHAT
PHAT
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOC
BOC
PHAT
PHAT
Operating Cash FlowLast quarter
$17.9M
$-166.8M
Free Cash FlowOCF − Capex
$-10.0M
$-167.0M
FCF MarginFCF / Revenue
-33.8%
-290.0%
Capex IntensityCapex / Revenue
93.9%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.6M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOC
BOC
PHAT
PHAT
Q4 25
$17.9M
$-166.8M
Q3 25
$4.9M
$-14.1M
Q2 25
$4.6M
$-62.7M
Q1 25
$2.6M
$-84.9M
Q4 24
$21.2M
$-266.8M
Q3 24
$5.2M
$-63.6M
Q2 24
$4.5M
$-70.7M
Q1 24
$2.4M
Free Cash Flow
BOC
BOC
PHAT
PHAT
Q4 25
$-10.0M
$-167.0M
Q3 25
$-489.4K
$-14.1M
Q2 25
$-2.7M
$-62.8M
Q1 25
$-4.3M
$-84.9M
Q4 24
$-11.0M
$-266.9M
Q3 24
$-1.2M
$-63.6M
Q2 24
$-4.3M
$-70.8M
Q1 24
$-6.0M
FCF Margin
BOC
BOC
PHAT
PHAT
Q4 25
-33.8%
-290.0%
Q3 25
-1.7%
-28.6%
Q2 25
-9.7%
-159.0%
Q1 25
-15.5%
-297.9%
Q4 24
-39.2%
-899.8%
Q3 24
-4.4%
-389.0%
Q2 24
-15.9%
-966.2%
Q1 24
-23.6%
Capex Intensity
BOC
BOC
PHAT
PHAT
Q4 25
93.9%
0.4%
Q3 25
18.9%
0.1%
Q2 25
25.9%
0.2%
Q1 25
24.7%
0.1%
Q4 24
115.3%
0.5%
Q3 24
23.2%
0.3%
Q2 24
32.6%
0.6%
Q1 24
33.1%
Cash Conversion
BOC
BOC
PHAT
PHAT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
3.97×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOC
BOC

Billboard Rentals$11.9M40%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$10.0M34%
GIG$7.3M25%
Other$608.4K2%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons